Pediatric intestinal failure and vascular access.

Abstract

Emerging developments in the care of intestinal failure (IF) patients have drastically improved their overall prognosis, with recently reported survival rates over 90%. IF patients remain an extremely complex population who benefit from specialized, multidisciplinary care. Advances in the provision of parenteral and enteral nutrition, progress in the management of IF-associated liver disease with parenteral fish oil and catheter-associated blood stream infection with ethanol lock therapy, and the availability of novel surgical interventions, such as the serial transverse enteroplasty procedure, have made this a dynamic health care field with the promise of ongoing improvements in outcomes for these patients.

Links

Publisher Full Text

Authors

Modi BP, Jaksic T

Institution

Department of Surgery and Center for Advanced Intestinal Failure, Children's Hospital Boston and Harvard Medical School, Fegan 3, 300 Longwood Avenue, Boston, MA 02115, USA. biren.modi@childrens.harvard.edu

Source

The Surgical clinics of North America 92:3 2012 Jun pg 729-43, x

MeSH

Pub Type(s)

Journal Article
Review

Language

eng

PubMed ID

22595718